Research Papers

25 of 833 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Abnormal repolarisation after a game of Jass.
Groot HE; Krikken JA.
Neth Heart J (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Abnormal repolarisation after a game of Jass.
Groot HE; Krikken JA.
Neth Heart J (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Does it take two to tango?
Mol D; Stel EA; Hof IE.
Neth Heart J (Unknown)
Published: 2024
2/6 Transparent
Embedding routine health care data in clinical trials: with great power comes great responsibility.
Handoko ML; de Man FS; Brugts JJ; van der Meer P; Rhodius-Meester HFM; Schaap J; van de Kamp HJR; Houterman S; van Veghel D; Uijl A; Asselbergs FW.
Neth Heart J (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Does it take two to tango?
Mol D; Stel EA; Hof IE.
Neth Heart J (Unknown)
Published: 2024
2/6 Transparent
Do not discriminate only on age for cardiovascular risk management!
Martens FMAC.
Neth Heart J (Unknown)
Published: 2023
2/6 Transparent
Cardiac telerehabilitation: current status and future perspectives.
Brouwers RWM; Scherrenberg M; Kemps HMC; Dendale P; Snoek JA.
Neth Heart J (Unknown)
Published: 2023
2/6 Transparent
Evaluation of an application for the self-assessment of lifestyle behaviour in cardiac patients.
Goevaerts WF; Tenbült-van Limpt NCCW; Lu Y; Kop WJ; Kemps HMC; Brouwers RWM.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The importance, consequences and treatment of psychosocial risk factors in heart disease: less conversation, more actio…
Kupper N; van den Houdt S; Kuijpers PMJC; Widdershoven J.
Neth Heart J (Unknown)
Published: 2023
2/6 Transparent
Exercise-based cardiac rehabilitation in stable angina pectoris: a narrative review on current evidence and underlying …
Heutinck JM; de Koning IA; Vromen T; Thijssen DHJ; Kemps HMC.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cardiac rehabilitation for patients with obesity: lessons learned from the OPTICARE XL trial.
den Uijl I; Sunamura M; Brouwers RMW; Stam HJ; Boersma E; van den Berg-Emons RJG; Ter Hoeve N.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Brief lifestyle advice in cardiac care: an experimental study on message source and framing.
IJzerman RVH; van der Vaart R; Breeman LD; van den Broek I; Keesman M; Kraaijenhagen RA; Reijnders T; Weerts M; Evers AWM; Scholte Op Reimer WJM; Janssen VR; BENEFIT consortium.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review …
Aarts HM; van Hemert ND; Meijs TA; van Nieuwkerk AC; Berg JMT; Wykrzykowska JJ; van Royen N; Schotborgh CE; Tonino PAL; IJsselmuiden A; Vossenberg TN; van Houwelingen GK; Slagboom T; Voskuil M; Delewi R.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cardiac output, cerebral blood flow and cognition in patients with severe aortic valve stenosis undergoing transcathete…
van Nieuwkerk AC; Hemelrijk KI; Bron EE; Leeuwis AE; Majoie CBLM; Daemen MJAP; Moonen JEF; de Sitter A; Bouma BJ; van der Flier WM; Baan J; Piek JJ; Biessels GJ; Delewi R; Heart-Brain Connection Consortium.
Neth Heart J (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Impact of implementing Dutch versus European guideline risk factor targets in older patients with ischaemic heart disea…
van Trier TJ; Snaterse M; Herings RMC; Overbeek JA; Peters RJG; Jørstad HT.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
National indication document and aortic valve replacement landscape in the Netherlands.
Eerdekens R; van Steenbergen G; El Farissi M; Demandt J; van 't Veer M; Daeter E; Timmers L; de Weger A; Medendorp N; Tonino P; Transcatheter Heart Valve Intervention Registry Committee; Cardiothoracic Surgery Registry Committee of the Netherlands Heart Registry.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coron…
Habibi Z; Luijkx J; Gho BCG; Ilhan M; Veenstra LF; Ruiters LAW; Stein M; van 't Hof AWJ; Rasoul S.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Percutaneous closure of postsurgical thoracic aorta pseudoaneurysms: the why, when, and how.
de Winter RJ.
Neth Heart J (Unknown)
Published: 2023
1/6 Transparent
Emergency transfemoral valve-in-valve transcatheter aortic valve implantation in patient with chronic type A aortic dis…
Aarts HM; van Nieuwkerk AC; Baan J; Delewi R; Beijk MAM.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of geriatric co-management on outcomes in hospitalised cardiology patients aged 85 and over.
Raijmann RCMA; Koek HL; Emmelot-Vonk MH; Swaving JGE; Agema WRP; Kerckhoffs APM; Keijsers CJPW.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant? : Pro: Provide pre-emptive treatment …
de Boer RA.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant? : Con: Do no harm to asymptomatic car…
Doevendans PA.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy.
van Lint FHM; Hassanzada F; Verstraelen TE; Wang W; Bosman LP; van der Zwaag PA; Oomen T; Calkins H; Murray B; Tichnell C; Beuren TMA; Asselbergs FW; Houweling A; van den Berg MP; Wilde AAM; James CA; van Tintelen JP.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Importance of exercise stress testing in evaluation of unexplained cardiac arrest survivor.
Bergeman AT; Robyns T; Amin AS; Wilde AAM; van der Werf C.
Neth Heart J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention.
Evertz R; van der Heijden T; Beukema R; Westra S; Meindersma E; van Deursen C; Vernooy K.
Neth Heart J (Unknown)
Published: 2023
2/6 Transparent